1. Academic Validation
  2. Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity

Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity

  • Nat Genet. 2011 Feb;43(2):132-7. doi: 10.1038/ng.749.
Ekkehart Lausch 1 Andreas Janecke Matthias Bros Stefanie Trojandt Yasemin Alanay Corinne De Laet Christian A Hübner Peter Meinecke Gen Nishimura Mari Matsuo Yoshiko Hirano Sylvie Tenoutasse Andrea Kiss Rafael Fabiano Machado Rosa Sharon L Unger Raffaele Renella Luisa Bonafé Jürgen Spranger Sheila Unger Bernhard Zabel Andrea Superti-Furga
Affiliations

Affiliation

  • 1 Centre for Pediatrics and Adolescent Medicine, Freiburg University Hospital, University of Freiburg, Freiburg, Germany.
Abstract

Vertebral and metaphyseal dysplasia, spasticity with cerebral calcifications, and strong predisposition to autoimmune diseases are the hallmarks of the genetic disorder spondyloenchondrodysplasia. We mapped a locus in five consanguineous families to chromosome 19p13 and identified mutations in ACP5, which encodes tartrate-resistant Phosphatase (TRAP), in 14 affected individuals and showed that these mutations abolish Enzyme function in the serum and cells of affected individuals. Phosphorylated osteopontin, a protein involved in bone reabsorption and in immune regulation, accumulates in serum, urine and cells cultured from TRAP-deficient individuals. Case-derived dendritic cells exhibit an altered cytokine profile and are more potent than matched control cells in stimulating allogeneic T cell proliferation in mixed lymphocyte reactions. These findings shed new LIGHT on the role of osteopontin and its regulation by TRAP in the pathogenesis of common autoimmune disorders.

Figures